Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
Kakolyris S, Samonis G, Koukourakis M, Vlachonicolis I, Chalkiadakis G, Kalbakis K, Souglakos I, Agelaki S, Toloudis P, Georgoulias V. Kakolyris S, et al. Among authors: agelaki s. Am J Clin Oncol. 1998 Oct;21(5):505-8. doi: 10.1097/00000421-199810000-00018. Am J Clin Oncol. 1998. PMID: 9781610 Clinical Trial.
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
Kakolyris S, Samonis G, Koukourakis M, Vlachonicolis J, Kalbakis K, Agelaki S, Chalkiadakis G, Sanidas E, Tsiftsis D, Georgoulias V. Kakolyris S, et al. Among authors: agelaki s. Am J Clin Oncol. 1999 Jun;22(3):273-7. doi: 10.1097/00000421-199906000-00012. Am J Clin Oncol. 1999. PMID: 10362335 Clinical Trial.
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
Mavroudis D, Kourousis C, Androulakis N, Kalbakis K, Agelaki S, Kakolyris S, Souglakos J, Sarra E, Vardakis N, Hatzidaki D, Sarmonis G, Georgoulias V. Mavroudis D, et al. Among authors: agelaki s. Am J Clin Oncol. 2000 Aug;23(4):341-4. doi: 10.1097/00000421-200008000-00005. Am J Clin Oncol. 2000. PMID: 10955859 Clinical Trial.
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Kakolyris S, Souglakos J, Agelaki S, Kourousis CH, Mavroudis D, Sarra E, Malliotakis P, Georgoulias V. Kakolyris S, et al. Among authors: agelaki s. Lung Cancer. 2000 Dec;30(3):193-8. doi: 10.1016/s0169-5002(00)00146-x. Lung Cancer. 2000. PMID: 11137204 Clinical Trial.
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Kakolyris S, Papadakis E, Tsiafaki X, Kalofonos C, Rapti A, Toubis M, Bania E, Kouroussis C, Chainis K, Androulakis N, Agelaki S, Sarra E, Vardakis N, Georgoulias V; Greek Cooperative Group for Lung Cancer. Kakolyris S, et al. Among authors: agelaki s. Lung Cancer. 2001 May;32(2):179-87. doi: 10.1016/s0169-5002(00)00212-9. Lung Cancer. 2001. PMID: 11325489 Clinical Trial.
163 results